文献速递牙周病

牙周积极治疗后10年支持性维护的临床治疗终点:回顾性队列研究

Clinical Treatment Endpoints After Active Periodontal Treatment and 10 Years of Supportive Periodontal Care: A Retrospective Cohort Study.
PubMed 文献 · J Clin Periodontol · 2025-07-08

该回顾性队列研究纳入128例牙周炎患者,在积极牙周治疗(APT/T1)后接受120±12个月支持性牙周维护(SPC/T2),比较四种临床终点(CEP)下的牙周稳定性。结果显示达到CEP1较难但可行,多数患者处于CEP2/CEP3;未达任何终点者探诊深度>5mm位点数和牙周失牙数显著增加。

要点

  • APT后10年SPC,仅少数患者达到CEP1(T1为7例,T2为6例)。
  • 未达任何CEP者PPD>5mm位点数显著增加且牙周失牙更多。
  • 达到CEP1、CEP2或CEP3在牙周失牙方面无显著差异。

核心结论

  • 通过全面APT达到CEP1是可能的,但慢性病治疗常导致较不理想的CEP2/CEP3。
  • APT后达到CEP1、CEP2或CEP3在牙周失牙方面未观察到差异。
  • 未达任何CEP者牙周失牙更多,PPD>5mm位点数显著增加。

研究设计与样本

  • 回顾性队列研究,纳入128例患者(年龄65.5±10.5岁;III期83例,IV期45例;B级47例,C级81例)。
  • 比较APT/T1与120±12个月SPC/T2时四种临床终点(CEP1–CEP4)及患者和牙相关参数。
  • 采用受试者工作特征分析评估CEP作为牙周失牙预测的截断值。

主要发现

  • T1时7例达CEP1,23例CEP2,45例CEP3,23例CEP4,30例无CEP。
  • T2时6例达CEP1,37例CEP2,38例CEP3,35例CEP4,12例无CEP。
  • 无CEP者PPD>5mm位点数显著增加,牙周失牙高于CEP1、CEP2和CEP3(p<0.001)。

关键数值与推荐

  • CEP1:PPD≤4mm,无≥4mm位点伴探诊出血(BOP),总BOP<10%。
  • CEP2:无PPD>4mm伴BOP或PPD≥6mm。
  • CEP3:PPD≥5mm位点≤4个。
  • CEP4:PPD≥5mm牙齿≤5颗。

临床怎么用

  • 临床可参考四种CEP评估APT后SPC期间的牙周稳定性。
  • 未达任何CEP者需警惕PPD>5mm位点增加及牙周失牙风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Comparing periodontal stability following active periodontal treatment (APT/T1) and 120 ± 12 months of supportive periodontal care (SPC/T2) using four clinical endpoints (CEPs). METHODS: CEP1: pocket probing depths (PPD) ≤ 4 mm, no sites with ≥ 4 mm with bleeding on probing (BOP), and total BOP < 10%; CEP2: no PPD > 4 mm with BOP or PPD ≥ 6 mm; CEP3: ≤ 4 sites with PPD ≥ 5 mm; CEP4: ≤ 5 teeth with PPD ≥ 5 mm. Assuming CEPs are mutually exclusive, patient- and tooth-related parameters (e.g., periodontal tooth loss: PTL) were compared. Using receiver operating characteristic analysis for the prediction of PTL as a cutoff for CEP was assessed. RESULTS: From 128 patients (age 65.5 ± 10.5 years; 83 stage III, 45 stage IV; 47 grade B, 81 grade C), 7 achieved CEP1, 23 CEP2, 45 CEP3, 23 CEP4, 30 noCEP at T1. At T2, six patients reached CEP1, 37 CEP2, 38 CEP3, 35 CEP4, 12 noCEP. For noCEP, the number of sites with PPD > 5 mm increased significantly, and PTL was higher compared to CEP1, CEP2 and CEP3 (p < 0.001). CONCLUSIONS: While achieving CEP1 is possible through comprehensive APT, treating a chronic disease often leads to less ideal CEP2/CEP3. Achieving CEP1, CEP2 or CEP3 after APT made no observable difference regarding PTL. TRIAL REGISTRATION: The study is registered with the United States National Library of Medicine in the clinical trials database (URL: https://clinicaltrials.gov; NCT03048045).

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Schröder M, Buchinger M, Dahmer I, et al. Clinical Treatment Endpoints After Active Periodontal Treatment and 10 Years of Supportive Periodontal Care: A Retrospective Cohort Study. J Clin Periodontol. 2025. PMID: 40629762. doi:10.1111/jcpe.14179

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。